Replies to post #17109 on Momenta Pharmaceuticals, Inc. (MNTA)

[DFRAI]

If same plant but different production line for 20 ml copaxone...is allowed to continue, a few questions

1. Plant violations affect new approvals only - setting up new production lines?
2. I presume that Pfizer would set up a new line for the 40ml and have it inspected by FDA - could this happen if the plant had "other general" violations?
3. I would stop the 20ml production line and convert it to 40ml and go after the 80% of the market if possible.

[DewDiligence]

20mg and 40mg use the same production line, according to MNTA's 4Q16 CC (#msg-128865663).